Discovery Search
Lead story · 2026·07·19 · 18:15 UTC
Kalshi Expands Into Biotech With Markets on Clinical Trials, FDA Drug Approvals
Discovery Search
This cluster tracks updates related to Kalshi Expands Into Biotech With Markets on Clinical Trials, FDA Drug Approvals. Coverage began with: Kalshi Expands Into Biotech With Markets on Clinical Trials, FDA Drug Approvals. Latest coverage: Kalshi Expands Into Biotech With Markets on Clinical Trials, FDA Drug Approvals.
Coverage
Coverage from 3 articles
Chronology
Timeline
Related stories
Related key player · Omen Feds Move To Block Arizona's Gambling Laws Against Kalshi - Law360
Related key player · Omen Novig Founder Isn’t Worried About Kalshi, Polymarket’s Head Start
Related key player · Federal Reserve Appeals court upholds Navarro contempt of Congress convictions
Related key player · UMA Protocol Polymarket Sued Over Alleged $6.5M “Bait-and-Switch” Scam
Related key player · Omen Warsh faces multiple alternative inflation signs as Fed charts new course
Related key player · Federal Reserve Trump's teleprompter operator on unpaid leave for alleged prediction market bets on Trump speeches
Read the prediction-market beat
Free, no signup needed. We do the cross-source comparison so you don't have to.
Browse latest